Therefore, we engineered the human uterus tumor cell line, HTB-114 to express the HLA pair DPA1*01:03/DPB1*04:01, with or without co-expression of the mutant full length N345K PIK3CA protein (Suppl. The gene discussed is HLA-DPA1; the disease is medical procedure.